Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Whole Brain, Cortical Grey Matter, and Thalamic Volume Changes During 5–7 Years of Ozanimod in Relapsing MS: Final Results from the DAYBREAK Open-label Extension Study

              Author:Cohen, Jeffrey A.   Arnold, Douglas L.   DeLuca, John   Hartung, Hans-Peter   Kappos, Ludwig   Comi, Giancarlo   Selmaj, Krzysztof W.   Steinman, Lawrence   Bar-Or, Amit   Montalban, Xavier   Havrdová, Eva K.   Sheffield, James K.   Pachai, Chahin   Cheng, Chun-Yen   Riolo, Jon V.   C,   

              Session Name:P3: Multiple Sclerosis: Imaging of Demyelinating and Neuroinflammatory Diseases  

              Topic:Multiple Sclerosis  

              Program Number:P3.005  

              Author Institution:Kessler Foundation, West Orange, New Jersey, and Department of Physical Medicine & Rehabilitation and Neurology & Neurosciences, Rutgers - New Jersey Medical School, Newark, New Jersey, USA, West Orange, NJ  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Sydney, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  and Department of Neurology, Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Headorgans, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  Vita-Salute San Raffaele University, and Casa di Cura Igea, Milan, Italy, Milan, Italy  Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, USA, Stanford, CA  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA, Philadelphia, PA  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Bristol Myers Squibb, Princeton, New Jersey, USA, Princeton, NJ  Bristol Myers Squibb, Princeton, New Jersey, USA, Bedminster, NJ